Abstract
BackgroundDifferent “huntingtin-lowering” therapeutic strategies based on RNA modulation are in early development for Huntington’s disease (HD). AimsThe aim of this study was to demonstrate the therapeutic potential of an antisense...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
